IFNG and melanoma: IL-12-responding ILC1s induce a signature TME characterized by strong upregulation of IFNγ and type I-associated chemokine receptors (CXCR6, CCR5, CXCR3, and CCR1) to recruit tumor invading Rorcfm+ILCs in a mouse model of melanoma (50).